Metrion Biosciences Limited, a specialist ion channel contract research and drug discovery company, has expanded its capabilities and expertise through the addition of automated low volume liquid handling capability and 384-well electrophysiology and fluorescence-based high throughput screening (HTS) assay systems.   In the newly created position of head of Screening Technologies, Dr. Gary Clark will lead the implementation of the expanded services as well as the company’s enhanced cell biology ...